1-3 of 3
Junan Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy of Once-Weekly Bortezomib with Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma

Natalia Gut, PharmD, RPh, Filiz Yucebay, PharmD, BCPS, BCOP, Jessica Dempsey, PharmD, Junan Li, PhD MS, Don M. Benson, Jr., MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1958.
https://doi.org/10.1182/blood-2018-99-111908
Published: 2018
Journal Articles

G-CSF Starting Day +1 after Autologous Transplant Is Safer Than Day +5 or Day +7 in Patients with Multiple Myeloma

Francesca Cottini, Douglas Sborov, Yu Kyoung Cho, Misty Lamprecht, Karen Tackett, Junan Li, Steven M. Devine, Ming Poi, Mitch A. Phelps, Craig C Hofmeister, MD MPH
Journal: Blood
Blood (2016) 128 (22): 5790.
https://doi.org/10.1182/blood.V128.22.5790.5790
Published: 2016
Journal Articles

Development of a Predictive Pharmacokinetic and Pharmacodynamic Model to Personalize Melphalan Dosing in Autologous Transplant for Patients with Multiple Myeloma

Yu Kyoung Cho, MS, Junan Li, PhD, Douglas W. Sborov, MD, Jiang Wang, PhD, Yue Gao, PhD, Misty Lamprecht, CNS, Ming Poi, PharmD, PhD, Mitch A. Phelps, PhD, Craig C Hofmeister, MD MPH
Journal: Blood
Blood (2014) 124 (21): 1086.
https://doi.org/10.1182/blood.V124.21.1086.1086
Published: 2014